Position in REGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$49,438,915
+$1,105,188 QoQ
Shares Held
63,987
+2.2% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 14.124744088643004.ToString("F0")%
Shared 0.ToString("F0")%
None 85.875255911357.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Dec 31, 2024CallValue
$1,210,961
CallShares
1,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $464,981,245 across 201 Biotechnology names. REGN ranks #2 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in REGN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,438,915 | 63,987 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $48,333,727 | 62,619 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $35,159,867 | 62,532 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,589,525 | 56,361 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $35,038,036 | 55,245 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,210,961 | 1,700 | Call | Sole | 2025-02-11 | |
| 2024-12-31 | $37,603,900 | 52,790 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $52,161,477 | 49,619 | Shares | Sole | 2024-11-08 | |
| 2024-09-30 | $210,248 | 200 | Put | Sole | 2024-11-08 | |
| 2024-06-30 | $49,652,759 | 47,242 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $39,059,769 | 40,582 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $36,581,656 | 41,651 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $33,521,629 | 40,733 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,768,489 | 37,254 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $29,184,075 | 35,518 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $25,496,735 | 35,339 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $23,726,060 | 34,442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,751,027 | 35,104 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,079,002 | 37,340 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,571,811 | 38,909 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,348,449 | 38,581 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,456,740 | 34,835 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $18,952,568 | 40,057 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,009,336 | 35,208 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $17,153,898 | 30,644 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $21,089,972 | 33,817 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $13,748,781 | 28,157 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||